RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 88 filers reported holding RAPT THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.25 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,868,562 | +104.7% | 1,315,798 | +130.3% | 2.39% | -13.1% |
| Q2 2023 | $10,682,057 | +34.5% | 571,233 | +32.0% | 2.74% | -60.6% |
| Q1 2023 | $7,943,715 | -7.3% | 432,900 | 0.0% | 6.97% | -13.1% |
| Q4 2022 | $8,571,420 | -17.7% | 432,900 | 0.0% | 8.02% | -17.1% |
| Q3 2022 | $10,416,000 | +31.8% | 432,900 | 0.0% | 9.67% | +43.9% |
| Q2 2022 | $7,900,000 | -17.0% | 432,900 | 0.0% | 6.72% | +21.5% |
| Q1 2022 | $9,519,000 | -40.1% | 432,900 | 0.0% | 5.53% | -38.8% |
| Q4 2021 | $15,900,000 | -19.4% | 432,900 | -31.8% | 9.04% | -5.7% |
| Q3 2021 | $19,722,000 | -15.7% | 635,177 | -13.7% | 9.59% | +26.3% |
| Q2 2021 | $23,391,000 | +43.2% | 735,801 | 0.0% | 7.59% | +38.9% |
| Q1 2021 | $16,335,000 | +12.4% | 735,801 | 0.0% | 5.46% | +77.7% |
| Q4 2020 | $14,532,000 | – | 735,801 | – | 3.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 2,680,621 | $44,551,921 | 29.58% |
| GREAT POINT PARTNERS LLC | 1,458,070 | $24,233,123 | 4.41% |
| Euclidean Capital LLC | 1,315,798 | $21,868,562 | 2.39% |
| Trustees of Columbia University in the City of New York | 73,383 | $1,219,625 | 2.24% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 805,828 | $13,392,861 | 1.54% |
| Perceptive Advisors | 1,920,658 | $31,921,336 | 1.06% |
| Deep Track Capital, LP | 1,500,000 | $24,930,000 | 0.96% |
| Cheyne Capital Management (UK) LLP | 20,000 | $332,400 | 0.96% |
| Alphabet Inc. | 540,270 | $8,979,287 | 0.58% |
| BRAIDWELL LP | 1,082,512 | $17,991,349 | 0.57% |